Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by Maxcitracon Jan 07, 2025 11:25am
162 Views
Post# 36392441

RE:RE:Exceptional Value

RE:RE:Exceptional Valuegojotv I fully agree, as Theralase Ruvidar data are getting better and better, more posters are coming on board and right away they are talking about selling Theralase to big pharma(acquisition).
Dr LBiati was brought on board to sign a Joint Venture deal with a big pharma, not to sell Theralase to a big pharma.
A joint venture deal will give Theralase the money needed to become a very big Canadian pharma giant.

gojotv! wrote: I love how Big Pharma's plants come to this board to try to sway investors to agree to acquisition...
You're not listening.
TLT longs are't looking to be bought up by some international firm for pennies on the pennies on the Canadian (lower) dollar.
We want our own, Canadian Big Pharma-Tech corporation to keep high-paying jobs here and to go keep oncology costs down, saving and even revitalizing our Canadian Healthcare System.
Every Canadian should profit from Theralase, which will pay out not only commercially, but by restoring dignity and quality of care to millions who have cancer as a fact of their lives.
Sell out to Merck... pfff!
These kids today - no vision!




<< Previous
Bullboard Posts
Next >>